ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients

Gut. 2005 Nov;54(11):1664.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Azathioprine / adverse effects*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Inflammatory Bowel Diseases / drug therapy*
  • Inosine Triphosphatase
  • Methyltransferases / genetics
  • Polymorphism, Genetic
  • Pyrophosphatases / genetics*

Substances

  • Immunosuppressive Agents
  • Methyltransferases
  • thiopurine methyltransferase
  • Pyrophosphatases
  • Azathioprine